Introduction
Alzheimer's disease (AD) is an age-dependent neurodegenerative disease which was first described by Alois Alzheimer in 1907. It is an irreversible and progressive neurodegenerative disease characterized by a group of cognitive and non-cognitive dysfunctions such as memory loss, language difficulties, psychiatric symptoms and behavioral disturbances (1, 2) . AD is a complex disorder and several hypotheses have been proposed for AD pathogenesis but the most important hypotheses suggested to the pathophysiology of AD include Cholinergic hypothesis and Amyloid cascade hypothesis (3) . Loss of cholinergic neurons and diminished level of acetylcholine neurotransmitter were observed in memory loss in AD patients, and restoration of brain cholinergic function by acetylcholinesterase inhibitors (AChEIs), symptomatically improves memory impairment in AD patients. According to this hypothesis, AChEI medications are currently available therapy for AD patients but these drugs are useful for symptomatic treatment and do not cure the disease (4) .
Two major pathological findings in the AD patient brains are extracellular senile plaques and intracellular neurofibrillary tangles. The major components of senile plaques are amyloid beta (Aβ) peptides. The Aβ peptides are 39-43 amino acid peptides produced by proteolytically cleavage of Aβ protein precursor protein (APP) by γ-secretase and β-secretase enzymes (5) . The "Amyloid cascade hypothesis" suggested that abnormal accumulation of Aβ peptide initiates a cascade resulted in neuronal dysfunction and death (6) . Various studies have indicated that Aβ peptide has neurotoxic properties both in vitro and in vivo (7, 8) . Several mechanisms proposed for the neurotoxicity of Aβ peptide include oxidative stress, mitochondrial dysfunction, interaction with ion channel, alterations in membrane permeability, alterations in glutamate receptors and excitotoxicity and induction of inflammatory responses (9) . The Aβ peptide plays a crucial role in the pathogenesis of AD, then modulation of Aβ toxicity is a major focus of several studies as an important therapeutic approach to control the onset and progressive of AD (10, 11) .
Because of complex pathophysiology of AD, single targeted drugs have limited effects and new researches are focusing on multi-targeted drugs (12) (13) (14) . Medicinal plants contain a variety of bioactive compounds with potent biological activities. Then, the medicinal plants appear to be a promising source for identification of bioactive compounds which can be used in the treatment of AD (15, 16) . Some herbal extracts have been effective in treating AD in animal models and even in clinical studies (17, 18) .
The plants of Rosaceae family are used in traditional and folklore medicine of many countries. Sanguisorba minor is a plant belonging to the genus Sanguisorba, a member of Rosaceae family. The plants of Sanguisorba spp. are rich in bioactive compounds and more than 120 compounds have been isolated from this genus including terpenoids, phenols and flavonoids. Sanguisorba plants have high amounts of polyphenols and have strong antioxidant activity. These plants also show neuroprotective activity. Studies have indicated that Sanguisorba spp. extracts inhibit AChE activity and the glycogen synthase kinase 3β (GSK3) (19, 20) . Both of these enzymes have important roles in AD (21) . Among Sanguisorba species, S. minor has been shown to have the most inhibitory effect on the AChE enzyme (22) .
Ferulago angulata is a medicinal plant from Apiaceae family, which is mostly indigenous to western Iran, Turkey and Iraq. Eight species exist in Iran of which three are native. The genus Ferulago is a source of biologically active compounds such as coumarins, sesquiterpenes, monoterpenes, phenylpropanoids and flavonoids. The genus Ferulago has different biological activities such as anti-inflammatory, antioxidant and anti-cancer and antidiabetic effects (23) . In addition, several neuroprotective activities were reported for Ferulago angulata extract (24, 25) . In the present study, anti-Alzheimer effects of S. minor and F. angulata were investigated in a primary neuron culture.
Materials and Methods
Dulbecco's modified Eagle's Medium (DMEM), fetal bovine serum (FBS), penicillin-streptomycin (10 000 U/ mL) and trypsin (0.25%) were taken from GIBCO (USA 
Plant extraction
The total extract was obtained by maceration method. The aerial parts of collected plants were dried in shade and ground. 100 mL of methanol: water (80:20) was added to 10 g of the plant powder. Every 24 hours, the mixture was filtered and fresh solvent was added for 3 days. All extracts were combined and dried by rotary evaporator and freeze dryer.
Measurement of total phenolic compounds
The total phenolics contents of the extracts were determined spectrophotometrically according to the Folin-Ciocalteu method using gallic acid as the standard. The methanolic solution of the extracts or gallic acid (400 µL) were mixed with Folin-Ciocalteu's reagent (3 mL) and incubated at 22℃ for 5 minutes. Then, 3 mL sodium carbonate (7 %) was added and the reaction mixture was further incubated at 22℃ for 90 minutes. The absorbance was then, determined at 725 nm. The total phenolics content was expressed as gallic acid equivalent in milligram per 100 g dried extract (17) .
Primary culture of cerebellar granule neurons Cerebellar granule neurons (CGNs) were cultured as described previously (26) . Cerebella were dissected from the brain of 6-7 day-old mice (BALB/c). A single cell suspension was obtained from dissected Cerebella by digestion with trypsin and triturating. Then, cell suspension was seeded on PDL-coated cell culture plates. Culture medium was DMEM containing 10% FBS, 25 mM KCl, 4.5 g/L glucose, insulin (100 mU/L), penicillin and streptomycin 1% (v/v). The cultured cell plates were maintained at 37℃ in a humidified atmosphere with 5% CO2. 48 hours after cell plating, the half of culture medium was replaced by medium containing cytosine β-D-arabinofuranoside (Ara-C) at a final concentration of 20 µM to inhibit the growth of non-neuronal cells. After that, the medium was not changed during culture. After 7 days of in vitro (DIV7) in this condition, MAP2 protein immune-staining indicated that more than 95% of cells in culture were neurons. Therefore, the cultured neurons were matured on DIV7 and all experiments were done on matured neurons.
Treatment
CGNs were plated onto PDL coated 96-well plate (1 × 10 5 cell/well) and on DIV 7, incubated with 10 µM aggregated Aβ alone or in combination with different concentrations of extracts for 24 hours, then the cell viability was measured by MTT assay. Aβ 25-35 was reconstituted in sterile water at a concentration of 1 mM. Aliquots were incubated at 37℃ for 72 hours to form aggregated amyloid. The stock solutions of the plant extracts were prepared by dissolving in DMSO. The diluted plant extracts were daily prepared by dilution of the stock solution by culture medium. The concentration of DMSO in the culture medium was 0.5% or less.
Cell viability test Neuronal survival was quantified by methyl tetrazolium salt (MTT) reduction assay. This assay is based on the ability of mitochondria dehydrogenase enzyme from viable cells to cleave the tetrazolium rings of the pale yellow MTT and form dark blue formazan crystals. After incubation time, the culture medium was replaced with MTT (0.5 mg/mL) containing medium and incubated for 4 hours, then the medium was removed and 100 mL DMSO was added to each well to dissolve formazan crystals. The absorbance was measured by ELISA reader (BIOTEK) at a wavelength of 570 against 630 nm as the reference wavelength. Data are expressed as the percentage of control (27) .
Measurement of reactive oxygen species
Reactive oxygen species (ROS) generation in cells was evaluated by a fluorescent probe 2,7-dichlorodihydrofluorescein diacetate (DCFH-DA). DCFH-DA crosses cell membranes and is hydrolyzed enzymatically to nonfluorescent dichlorodihydrofluorescein (DCFH). It is often used as an indicator of ROS. ROS in the cells cause oxidation of DCFH and convert it to highly fluorescent dichlorofluorescein (DCF) compound. Cells were plated onto PDL coated 96-well plate (1 ×10 5 cell/well), on DIV7, incubated with 10 μg/mL Aβ alone or with extracts of F. angulata (50 μg/mL) and S. minor (75 μg/mL) for 24 hours. After the incubation time, the medium was replaced by fresh medium containing 10 µM DCFH-DA and incubated at 37℃ for 15 minutes. Then, the medium was removed and the cells were rinsed twice with Ca 2+ -free PBS. The fluorescence was monitored by Fluorescence microplate reader (BIOTEK) at the excitation wavelength of 488 nm and the emission wavelength of 525 nm (28) .
Measurement of glutathione peroxidase Glutathione peroxidase (GPx) activity in CGNs was measured by the colorimetric kit (BioVision). CGNs were plated onto PDL coated 6-well plate (3 ×10 6 cell/well), on DIV 7, incubated with 10 µM Aβ alone or with extracts of F. angulata (50 μg/mL) and S. minor (75 μg/mL) for 24 hours. After the incubation, the cells were washed with PBS and removed from culture plate, then, homogenized in PBS with sonication. The homogenate was centrifuged at 1000 g for 10 minutes and the supernatant was used for enzyme activity and protein assay. GPx activity was measured according to kit instruction. Data were expressed as mU/mg protein. The amount of protein was obtained by Bradford method.
Measurement of acetylcholinesterase activity CGNs were plated onto PDL coated 6-well plate (3 ×10 6 cell/well), on DIV 7, incubated with 10 µM Aβ alone or with extracts of F. angulata (50 μg/mL) and S. minor (75 μg/mL) for 24 hours. Also, the effect of different concentrations of extracts on AchE activity of CGNs was measured. For this end, the cultured CGNs were incubated with different concentrations of each extract on DIV 7 and AChE activity was measured after 24 hours. After the incubation, the cells were washed with PBS and removed, then, homogenized in PBS with sonication. The homogenate was centrifuged at 1000 g for 10 minutes and the supernatant was used for enzyme activity and protein assay. AChE activity was determined using Ellman's method (29) . Briefly, Ellman reagent (100 µL) containing phosphate buffer (pH = 8, 0.1 M), ATCh 75 mM as a substrate, and dithionitrobenzoic acid (DTNB) 10 mM in a ratio of 150:2:5, was transferred to the 96-well plate and then 50 µL cell lysate was added to the reaction mixture as an enzyme source. The absorbance was measured at 405 nm for 15 minutes. A blank containing all components except cell lysate was run in parallel with a sample to eliminate the spontaneous and non-enzymatic breakdown of DTNB, and then the reactions rate was calculated. The amount of protein was obtained by Bradford method.
LD 50 estimation The LD 50 was estimated by the limit test method according to the OECD protocol. According to this protocol, one female animal is orally administered a single dose of 2000 mg/kg by gavage and the animal is monitored for 48 hours. If an animal dies the main test conducts, if not, four additional animals are gavaged the same dose. If three or more animals survive, the LD 50 is greater than 2000 mg/ kg. In the present study, because the first mice survived, four additional mice were gavaged the same dose of 2000 mg/kg, sequentially. Because all mice were survived, LD 50 was considered to be more than 2000 mg/kg for both extracts. All animals were evaluated for 14 days in terms of mortality, apparent health and weight (30) .
Statistical analysis
Results are expressed as mean ± standard error (SE). Statistically significant differences between groups were evaluated by one-way ANOVA followed by Tukey post hoc test. GraphPad PRISM 6 software was used for statistical analyses. P < 0.05 was considered to indicate a statistically significant difference.
Results

Amount of total phenolic compounds in the extracts
The total phenolic contents of the extracts were 11.06 ± 0.55 and 2.11 ± 0.08 for S. minor and F. angulate extracts respectively. The data were obtained according to calibration curves of gallic acid (y=2.6x-0.038, r2=0.99). The amount of phenolic compounds in the extracts are shown as equivalent of the gallic acid (mg) in 100 g dry extract.
Protective effects of Sanguisorba minor and Ferulago angulata extracts on Aβ-induced cytotoxicity Effects of S. minor and F. angulata extracts on Aβ-induced cytotoxicity in cultured CGNs are shown in Figure 1 . Treatment of CGNs with Aβ (10 µM) for 24 hours significantly reduced the cell viability (P < 0.001). Co-treatment of the CGNs with different concentrations of S. minor extract and Aβ significantly reduced the Aβ-induced cytotoxicity. The maximum protective effect was observed at 75 µg/mL concentration, and above this concentration had less protective effect ( Figure 1A) . Also, F. angulata extract at concentration range of 5-200 µg/ mL could attenuate Aβ-induced cytotoxicity and at the concentration of 50 µg/mL the most protective effect was observed ( Figure 1B) . In Figure 1C the protective effects of the extracts are compared with protective effects of donepezil, BHT and memantine against the Aβ-induced cytotoxicity in CGNs. According to the results, the extracts had more protective effect than donepezil, BHT and memantine.
Effect of Sanguisorba minor and Ferulago angulata on ROS production ROS production was measured by fluorimetric method. The result indicated that incubation of CGNs with Aβ (10 µM) significantly increased fluorescent intensity which indicates significant ROS production. Both S. minor (75 μg/mL) and F. angulata (50 μg/mL) significantly ameliorated Aβ-induced ROS production in CGNs. Also, S. minor (75 μg/mL) and F. angulata (50 μg/mL) alone did not affect ROS level in CGNs (Figure 2 ).
Effect of Sanguisorba minor and Ferulago angulata on GPx activity
GPx is the most important antioxidant enzyme in the cells. Treatment of CGNs with Aβ (10 µM) significantly decreased GPx activity as compared with the control group. When cells were co-treated with Aβ (10 µM) and S. minor extract (75 μg/mL) or with Aβ (10 µM) and F. angulata extract (50 μg/mL) for 24 hours, GPx activity significantly increased as compared with Aβ group (Figure 3) .
Effect of Sanguisorba minor and Ferulago angulata on AChE activity
The CGNs were treated with different concentrations of S.minor extract (5-100 μg/mL) and F. angulata extract (10-200 μg/mL), and AChE activity was measured after 24 hours. Results indicated that S. minor extract dose dependently reduced the enzyme activity ( Figure 4A ) but F. angulata extract about 50% reduced enzyme activity even in high concentration ( Figure 4B ). Effect of Aβ and Aβ +extract on AChE activity was also investigated. Aβ treatment significantly increased the AChE activity in CGNs. Co-treatment of Aβ with both extracts significantly decreased the AChE activity as compared with Aβ group ( Figure 4C ). LD 50 test According to OECD protocol, limit test was performed for estimation of LD50. Because all the animals which treated 2000 mg/kg extract survived, LD50 was considered to be more than 2000 mg/kg for both extracts. Treated animals were monitored for 14 days. There was no illness in apparent health during the observed period and a significant difference in body weight changes was not observed between extract treated and control groups.
Discussion
In the present study neuroprotective effects of S. minor and F. angulata extracts against Aβ-induced toxicity in cultured CGNs were investigated. The CGNs grew and developed after birth and produced a homogeneous population of neurons in culture, Therefore, primary culture of CGNs was used as a suitable model for studying cellular and molecular mechanisms of neural cell apoptosis, survival, neurodegeneration and neuroprotection (31) . Also CGNs culture was used for studying the neurotoxicity of Aβ peptide (26, 32) .
Results of the present study indicated that S. minor and F. angulata extracts significantly ameliorated the Aβ-induced cytotoxicity in cultured CGNs. Also, Aβ-induced increase in ROS production and decrease in GPx activity, as an antioxidant enzyme, were significantly restored by pretreatment with S. minor and F. angulata extracts which indicates that Aβ-induced oxidative stress was significantly attenuated by these extracts. Several studies have reported that Aβ peptide in aggregated form produced neurotoxicity and has a pivotal role in neural cell loss and progression of AD disease and also oxidative stress plays crucial roles in Aβ-induced toxicity (8, 33, 34) . Medicinal plants which are rich in polyphenol compounds have strong antioxidant activity and protects neurons from oxidative insults (35) . Several medicinal plants such as Gingko biloba, Crocus sativus, Curcuma longa and Melissa officinalis have been shown to prevent oxidative stress in cultured neurons and brain tissue that is associated with AD (18). Our results indicated that S. minor and F. angulata extracts had 11.06 ± 0.55 and 2.11 ± 0.08 mg/g dried extract total phenol contents, respectively. This finding indicated that S. minor has a high level of phenolic compounds which is in agreement with a previous study (20) . Sanguisorba species have potent antioxidant activities and some studies have reported the neuroprotective effects for plants of this species. Sanguisorbae officinalis root extract has elicited neuroprotective activity and protect cortical neuron culture from H2O2-induced oxidative stress (36) . In addition, S. minor could significantly scavenge the peroxyl (H2O2) and hydroxyl (OH) radicals. The genus Sanguisorba contains several biologically active compounds and to date, more than 120 compounds have been isolated and identified from them. Among these compounds, phenols and flavonoids are responsible for the antioxidant properties of these plants. Gallic acid, quercetin and ellagic acid are polyphenolic compounds isolated from S. minor extract (20) . These polyphenolic compounds have neuroprotective activity and protect cultured neurons and brain tissue against oxidative damages caused by Aβ peptide (37) (38) (39) . Then, it is suggested that neuroprotective effect of S. minor against Aβ-induced toxicity, at least partly, is due to the presence of these phenolic compounds.
Ferulago angulata is a plant belongs to Apiaceae family. In traditional medicine, it is used as a sedative agent (23) . Neuroprotective activity has been reported for F. angulata extract by several studies. Hydro-alcoholic extract of F. angulata improves locomotor activity, anxiety, memory and pain in animal models of ischemia (24, 25) . Also, F. angulata extract attenuates oxidative stress in brain tissue in a rat model of Parkinson's disease (40) . Essential oil of F. angulata has cognition-enhancing effect and improves scopolamine-induced memory impairment and oxidative stress (41) . In the present study, F. angulata extract significantly ameliorated Aβ-induced neuronal cell death and attenuated Aβ-induced ROS production and oxidative stress. F. angulata extract contains phenolic and flavonoid compounds and has potent antioxidant activity. The neuroprotective activity of the extract has been attributed to these compounds (25) . The phenolic and flavonoid compounds have antioxidant activities directly by radical scavenging of the free radicals or indirectly through upregulation of cellular antioxidant defense pathways which provides neuroprotection against oxidative damage. In addition to antioxidant activity, polyphenols protect neural cells against oxidative insults through activation of cell survival signaling pathways such as MAP kinase and PI3K/Act (42) .
AChE enzyme has a crucial role in Aβ toxicity and progression of AD. Increased activity of AChE around the amyloid plaques has been observed in the AD brain and also AChE protein has been found to be abundant in amyloid plaques and co-localized with Aβ peptide (43) . It is reported that AChE protein stimulates Aβ peptide aggregation and produces AChE-Aβ complex which is more neurotoxic than Aβ alone (44) . On the other hand, the in vitro studies have indicated that exposure of cultured neurons to Aβ peptide increases AChE activity (45) . Similar findings have been observed in animal studies and injection of Aβ peptide in the brain increases brain AChE activity which is associated with learning and memory deficit (17) . AChE inhibitors such as donepezil, rivastagmine and galantamine are commonly used for the treatment of AD. Inhibition of AChE activity increases the brain acetylcholine level which is resulted in improved memory function. Besides of this mechanism, AChE inhibitors attenuate the Aβ-induced toxicity and oxidative stress (11) . Then, inhibition of AChE is an approach to reduce the Aβ-induced neurotoxicity. In addition, inhibition of Aβ-induced AChE activity, boosts brain cholinergic function and improves AD symptoms. In the present study, S. minor extract dose-dependently inhibited AChE activity in cultured CGNs. At dose of 100 μɡ/mL significant inhibition of AChE activity about (80%) was observed. This finding is accordance with a previous study which reported that S. minor extract inhibits pure AChE from red blood cells (22) . Also our results indicated that Aβ exposure for 24 hours significantly increased AChE activity in cultured CGNs. S. minor extract significantly inhibited the AChE activity which was elevated by Aβ exposure. According to these findings, it is concluded that AChE inhibitory effect of S. minor extract was contributing to its protective effect against Aβ neurotoxicity.
Ferulago angulata extract inhibited AChE activity too, but its effect was less than S. minor extract and maximum effect (about 50% inhibition) was observed at 200 μg/ mL concentration. This finding is in accordance with a previous study which reported weak AChE inhibitory effect for F. angulata extract (46) . Despite the low AChE inhibitory effect, F. angulata extract significantly reduced the increased AChE activity induced by Aβ treatment. The exact mechanisms by which Aβ increases AChE activity and expression in the cell culture and amyloid plaques in the brain are not known. There is some evidence that Aβ-induced oxidative stress and disruption of calcium homeostasis are involved (45) . The oxidative stress increases AChE activity and this increase is ameliorated with antioxidants which do not have AChE inhibitory effect (26, 47) . According to these reports and our findings, it is concluded that F. angulata extract restores the increases in the Aβ-induced AChE activity by reduction of Aβ-induced oxidative stress. Although other mechanisms may be involved which needs further investigation.
The results of LD 50 experiment of these extracts showed that LD50s of both extracts were higher than 2000 mg/kg. According to the OECD protocol, they are considered to be non-toxic compounds and can be safely used.
Conclusion
Our study indicated that S. minor and F. angulata extracts could improve Aβ-induced cytotoxicity and oxidative stress. It is suggested that protective effects of both extracts are due to their antioxidant activities. Also, for S. minor extract the AChE inhibitory effect of the extract may be involved. According to these findings, further studies are suggested to evaluate the effects of S. minor and F. angulata extracts as therapeutic agents in AD.
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